Henrik J. Ditzel
Sdr. Boulevard 29
Odense, 5000, Denmark
Odense, 5000, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 158 publications
Stable global repertoire architecture masks short-term clonal remodeling in intratumoral TCR repertoires.
Journal: Frontiers in immunology
Published: February 28, 2026
Dual PI3K/mTOR inhibition is required to combat resistance to CDK4/6 inhibitor and endocrine therapy in PIK3CA-mutant breast cancer.
Journal: Science translational medicine
Published: December 17, 2025
Vaccination of individuals undergoing immunosuppressive therapy
Journal: Ugeskrift for laeger
Published: November 21, 2025
Adoptive cell transfer therapy with ex vivo primed peripheral lymphocytes in combination with chemotherapy in locally advanced or metastatic triple-negative breast cancer: the ImmunoBreast phase Ib clinical trial.
Journal: Journal for immunotherapy of cancer
Published: November 13, 2025
Association between Geriatric 8 frailty and overall survival, treatment intensity, and treatment tolerance in older patients with cancer (PROGNOSIS-G8).
Journal: Journal of geriatric oncology
Published: October 30, 2025
Systematic design of DMBT1-derived peptides correlating physicochemical properties and sequence motifs with siRNA delivery and efficacy in cancer therapy.
Journal: EBioMedicine
Published: April 22, 2025
JNK pathway suppression mediates insensitivity to combination endocrine therapy and CDK4/6 inhibition in ER+ breast cancer.
Journal: Journal of experimental & clinical cancer research : CR
Published: April 15, 2025
Stochastic demethylation and redundant epigenetic suppressive mechanisms generate highly heterogeneous responses to pharmacological DNA methyltransferase inhibition.
Journal: Journal of experimental & clinical cancer research : CR
Published: December 03, 2024
Genomic profiling and expanded use of targeted anticancer drugs in solid cancers with exhausted evidence-based treatment options (PRECODE): study protocol of a prospective, non-randomized, cohort study.
Journal: BMC medical genomics
Published: October 09, 2024
RET inhibition overcomes resistance to combined CDK4/6 inhibitor and endocrine therapy in ER+ breast cancer.
Journal: Frontiers in oncology
Published: September 16, 2024
Gastrin-releasing peptide receptor as theranostic target in estrogen-receptor positive breast cancer: A preclinical study of the theranostic pair [55Co]Co- and [177Lu]Lu-DOTA-RM26.
Journal: Nuclear medicine and biology
Published: June 11, 2024
Last Updated: 09/26/2026